Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver ...

MELD 3.0 is superior to other MELD-based scores for long-term prognostication in hospitalized patients with cirrhosis, while GEMA-Na demonstrated even more accurate and better performance. The ...

As it has been clearly shown that waiting time is not an accurate marker of waiting list mortality, [27] the “sickest first” policy has been widely adopted for organ allocation, with the aim of ...

Although there have been no prospective studies that assess the usefulness of preoperative risk assessment with either the CTP or MELD scores, the published data provide a basis for general ...

Adoption of a new version of the Model for End-Stage Liver Disease, known as MELD 3.0, closed the gap in access to liver transplant between men and women, an analysis showed. Since MELD 3.0 was ...

Researchers have unveiled a groundbreaking advancement in liver failure care: the CATCH-LIFE-MELD score (Chinese Acute-on-Chronic Liver Failure Consortium (CATCH-LIFE)-MELD score). This innovative ...

People with severe acute-on-chronic liver failure (ACLF) were more likely to die than those without ACLF while waiting for a liver transplant, despite having similar survival rates if they did get a ...

Rochester, Minn.-based Mayo Clinic developed an artificial intelligence model using electrocardiogram data that outperformed the current model for end-stage liver disease score in predicting severe ...

Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the waitlist for a liver transplant, more likely to receive a transplant, and less ...